Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Anumana
AnumanaAnumana Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Anumana match what happens in practice?
Public evidence
Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm
SignalHunt:validation:Anumana
Public evidence
Anumana Announces Issuance of New American Medical Association CPT® Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction
SignalHunt:validation:Anumana
Public evidence
Anumana is advancing early detection of cardiovascular disease by embedding clinically validated AI directly into routine ECG workflows, supporting decision-making from primary care through cardiac subspecialty settings.
SignalHunt:validation:Anumana
Public evidence
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
SignalHunt:validation:Anumana
Public evidence
Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG
SignalHunt:validation:Anumana
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 8 public external signal(s) across 2 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Anumana through regulatory records, a published study, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Anumana. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Anumana is an AI-powered software that analyzes standard 12-lead ECG data. It identifies signs of low ejection fraction in patients during routine cardiovascular screenings.According to Anumana
What Anumana states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The ECG-AI LEF algorithm identifies low ejection fraction from standard 12-lead ECG data.
According to Anumana
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Reported publicly
How widely is this actually used?
Reported deployment
Anumana Announces Issuance of New American Medical Association CPT® Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction
Reported publicly
How widely is this actually used?
Reported outcome
Anumana is advancing early detection of cardiovascular disease by embedding clinically validated AI directly into routine ECG workflows, supporting decision-making from primary care through cardiac subspecialty settings.
Reported publicly
Are you seeing this result?
Recent change
Anumana Receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm
Reported publicly
Have you noticed this shift?
Recent change
Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Anumana is an AI-driven health technology company founded in 2021 through a partnership between nference and Mayo Clinic. The company focuses on developing software-as-a-medical-device (SaMD) solutions that leverage artificial intelligence to enhance cardiovascular care. Their flagship product, ECG-AI™ LEF, is…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings, US, Europe
Key strength
Regulatory: FDA 510(k) cleared, FDA Breakthrough Device designation
Key capabilities
ECG-based AI detection of low ejection fraction (LEF), Clinical validation in diverse patient populations, Integration with existing ECG systems
Clinical use cases
Early detection of heart failure through LEF identification, Integration of AI-driven diagnostics into primary care workflows, Enhancement of cardiovascular disease detection in outpatient clinics
Who uses it
Cardiologists, Electrophysiologists, Primary care clinicians
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Anumana accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Across the category
Anumana against the rest of Imaging & Diagnostics
Category intelligence reads this as Established. A sample of peers, not a census of the category.
Where Anumana may differ
Differences in what we have recorded. Never a ranking, never a quality judgement.
No first-hand account has been recorded for Anumana or for any peer we sampled in this category.
A gap across the whole category, not a fact about this technology.
Two readings that disagree
- Category intelligence reads clinical reality here as "Expanding", yet no first-hand account appears in the systems we sampled. Both readings are shown rather than reconciled.
Used another system in Imaging & Diagnostics? How does your experience compare?
A comparison across two systems tests the category, not just one product.
Connected intelligence
Category intelligence